Literature DB >> 26427978

Use of Bicarbonate in Patients With Metabolic Acidosis.

Myra F Ellis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26427978     DOI： 10.4037/ccn2015502

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN： 0279-5442            Impact factor:   1.708


× No keyword cloud information.
  3 in total

1.  Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Mische Holland; Elisabet Bjanes; Victor Nizet; Nicholas Dillon
Journal:  J Antimicrob Chemother       Date:  2022-02-02       Impact factor: 5.758

Review 2.  Bicarbonate Therapy for Critically Ill Patients with Metabolic Acidosis: A Systematic Review.

Authors:  Sanniya Khan Ghauri; Arslaan Javaeed; Khawaja Junaid Mustafa; Anna Podlasek; Abdus Salam Khan
Journal:  Cureus       Date:  2019-03-22

3.  Bicarbonate Therapy in Renally Compromised Critically Ill Patients with Metabolic Acidosis: Study of Clinical Outcomes and Mortality Rate.

Authors:  Zakia Rafique; Muhammad Haseeb Tariq; Arif-Ullah Khan; Muhammad Junaid Farrukh; Nida Khan; Ahmed Mujadid Burki; Khalid Mehmood
Journal:  Int J Gen Med       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.